Expression of Periostin and VEGF in the tissue of esophageal carcinoma and their signifi-cance
10.13315/j.cnki.cjcep.2014.12.006
- VernacularTitle:食管鳞状细胞癌组织中Periostin、VEGF的表达及意义
- Author:
Chao LI
;
Xiaoling XU
;
Ling WANG
;
Shan QIN
;
Yuqi ZHU
- Publication Type:Journal Article
- Keywords:
esophageal neoplasms;
squamous cell carcinoma;
Periostin;
VEGF;
invasion;
metastasis;
immunohistochemistry
- From:
Chinese Journal of Clinical and Experimental Pathology
2014;(12):1350-1353
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To investigate the expression of Periostin and VEGF protein in esophageal squamous cell carcinoma tissue and their significance. Methods Immunohistochemical staining (SP method) was used to detect Periostin and VEGF expression in 130 cases of esophageal squamous cell carcinoma and 130 cases of normal esophageal mucosa tissues. Results There was a significantly difference between esophageal squamous cell carcinoma and normal esophageal mucoma ( P<0. 05 ) . The expression of Periostin was related to the depth of invasion and the metastasis of lymph node (P<0. 05). A dramatic correlation has been found in the expression of VEGF to the degrees of differentiation, the depth of invasion and the metastasis of lymph node (P<0. 05). The expression of Peri-ostin was also positively correlated with the expression of VEGF (P<0. 05). Follow-up data was available in 66 cases with a range of 1 to 48 months. Kaplan-Meier survival curve showed survival rate of Periostin-positive group was significantly lower than that of Perios-tin-negative group (P<0. 05). The survival rate of VEGF-positive group was significantly lower than that of VEGF-negative group (P<0. 05). Conclusion The expression of Periostin has a close relationship with VEGF in the carcinogenesis, combined detection of both Periostin and VEGF can become an objective target to evaluate Potentials of invasion and lymph node metastasis of esophageal squamous cell carcinoma, which has a great significance to the judgment of prognosis in esophageal squamous cell carcinoma.
